Navigation Links
Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook
Date:2/14/2008

MELVILLE, N.Y., Feb. 14 /PRNewswire-FirstCall/ -- Gentiva Health Services, Inc. (Nasdaq: GTIV), the nation's leading provider of comprehensive home health and related services, today reported the following financial results for the fourth quarter ended December 30, 2007:
-- Net revenues increased 7% to $313.4 million versus the fourth quarter

ended December 31, 2006.

-- Net income rose 60% to $8.8 million, or $0.31 per diluted share, versus

$5.5 million, or $0.20 per diluted share, for the prior year period.

Average diluted shares were 28.8 million versus 28.2 million in the

2006 fourth quarter.

-- Earnings before interest, taxes, depreciation and amortization (EBITDA)

increased 33% to $25.3 million.

-- EBITDA and net income per diluted share, excluding Healthfield-related

restructuring and integration costs in both periods, were $25.6 million

and $0.31 for the fourth quarter of 2007 as compared to $22.3 million

and $0.27 for the 2006 fourth quarter.

-- EBITDA as a percentage of net revenues, excluding Healthfield-related

restructuring and integration costs, was 8.2% in the 2007 fourth

quarter versus 7.6% in the prior year period.

(Logo: http://www.newscom.com/cgi-bin/prnh/20060323/NYTH117LOGO )

"Gentiva's performance in the fourth quarter completes another solid year of progress for the Company," said Gentiva Chairman and CEO Ron Malone. "Our results for the quarter and the year were driven by the ongoing expansion of Home Health, the launching of new specialty programs and their contribution to double-digit Medicare >

other 121,222 110,179 466,672 423,346

Total net revenues $313,396 $293,118 $1,229,297 $1,106,588

A reconciliation of EBITDA to

Net income - As Reported amounts follows: (4)

4th Quarter Fiscal Year

2007 2006 2007 2006

EBITDA (5) (6) $25,303 $18,987 $99,676 $69,284

Depreciation and

amortization (7) (5,308) (3,850) (20,013) (15,241)

Interest expense, net (8) (5,868) (6,538) (24,081) (21,401)

Income before income taxes 14,127 8,599 55,582 32,642

Income tax expense (9) (5,281) (3,087) (22,754) (11,866)

Net income - As Reported $8,846 $5,512 $32,828 $20,776

A reconciliation of Net income per diluted share - As

Adjusted and Net income per diluted

share - As Reported follows: 4th Quarter Fiscal Year

2007 2006 2007 2006

Net income per diluted share:

As Adjusted $0.36 $0.31 $1.38 $1.03

Equity-based compensation (5) (0.05) (0.04) (0.18) (0.14)

Excluding special items and

restructuring and

integration costs 0.31 0.27 1.20 0.89

Restructuring and

integration costs (6A) - (0.07) (0.05) (0.17)

Medicare cost report

settlement (6B) - - - 0.04

As Reported $0.31 $0.20 $1.15 $0.76

Notes:

1) The Company's senior management evaluates performance and allocates

resources based on operating contributions of the reportable segments,

which exclude corporate expenses, depreciation, amortization, and

interest expense (net), but include revenues and all other costs

directly attributable to the specific segment.

2) Fiscal 2006 results included approximately $1.9 million recorded and

received from the total settlement of $5.5 million relating to the

Company's appeal filed with the U.S. Provider Reimbursement Review

Board ("PRRB") on the reopening of all of its 1999 cost reports.

3) Corporate expenses for the fourth quarter and fiscal 2007 included a

credit of $0.8 million relating to an adjustment of remaining lease

obligations associated with a 2002 restructuring plan and a net charge

of $1.1 million relating to miscellaneous adjustments. Corporate

expenses for the fourth quarter and fiscal 2006 included a credit of

approximately $0.9 million relating to legal settlements.

4) EBITDA, a non-GAAP financial measure, is defined as income before

interest expense (net of interest income), income taxes, depreciation

and amortization. Management uses EBITDA to evaluate overall

performance and compare current operating results with other companies

in the healthcare industry. EBITDA should not be considered in

isolation or as a substitute for net income, operating income or cash

flow statement data determined in accordance with accounting

principles generally accepted in the United States. Because EBITDA is

not a measure of financial performance under accounting principles

generally accepted in the United States and is susceptible to varying

calculations, it may not be comparable to similarly titled measures in

other companies.

5) EBITDA included equity-based compensation expense for the fourth

quarters of 2007 and 2006 of approximately $1.7 million and $1.3

million, respectively, resulting from the adoption of Statement of

Financial Accounting Standards No. 123 (Revised) "Share-Based Payment"

(SFAS 123(R)) as of January 2, 2006. Corresponding amounts for fiscal

2007 and 2006 were $6.8 million and $4.3 million, respectively. Such

amounts were reflected in corporate expenses.

6) Components of EBITDA included the following:

A) Restructuring and integration costs for the fourth quarter and

fiscal 2007 were $0.3 million and $2.4 million, respectively, and

for the fourth quarter and fiscal 2006 were $3.3 million and $7.7

million, respectively. These costs included the following items:

(i) $0.3 million and $2.4 million for the fourth quarters of 2007

and 2006, respectively, and $2.3 million and $6.1 million for

fiscal 2007 and 2006, respectively, resulting from restructuring

and integration activities relating to the Healthfield

acquisition; (ii) $0.1 million for fiscal 2007 and $0.9 million

for both the fourth quarter of 2006 and fiscal 2006 in connection

with a restructuring plan associated with the Company's hospice

operations; and (iii) $0.7 million for fiscal 2006 resulting from

a restructuring plan associated with the Company's CareCentrix

operations.

Restructuring and integration costs for the fourth quarters and

fiscal 2007 and 2006 were reflected as follows for segment

reporting purposes (dollars in millions):

4th Quarter Fiscal Year

2007 2006 2007 2006

Home Health $0.1 $0.6 $0.6 $2.3

CareCentrix - - - 0.7

Other Related Services - 0.9 0.1 0.9

Corporate expenses 0.2 1.8 1.7 3.8

Total $0.3 $3.3 $2.4 $7.7

B) A special item -- further described in Note 2 above -- relating to

a Medicare cost report settlement of $1.9 million for fiscal 2006,

was reflected in the Home Health segment.

Excluding the items described in Notes 6A and 6B above, EBITDA for the

fourth quarters of 2007 and 2006 would have been $25.6 million and

$22.3 million, respectively, and for fiscal 2007 and 2006 would have

been $102.1 million and $75.1 million, respectively.

7) Depreciation and amortization reflected amortization of identifiable

intangible assets of $1.0 million and $3.9 million, respectively, for

the fourth quarter and fiscal 2007, and $0.9 million and $3.3 million,

respectively, for the fourth quarter and fiscal 2006.

8) Interest expense, net, included interest expense on a term loan, fees

associated with a $75 million revolving credit facility and

amortization of debt financing costs, net of interest income.

9) The Company's effective tax rate was 37.4% and 40.9% for the fourth

quarter and fiscal 2007, respectively, and 35.9% and 36.4% for the

fourth quarter and fiscal 2006, respectively. The impact of the

adoption of SFAS 123(R) resulted in an increase in the Company's

effective tax rate of 2.0% and 2.3% in the fourth quarter and fiscal

2007, respectively, and 3.8% and 3.5% in the fourth quarter and fiscal

2006, respectively. In addition, the recognition of state net

operating loss carryforwards and the release of certain tax reserves

resulted in decreases in the Company's effective tax rate of 4.3% and

1.6% in the fourth quarter and fiscal 2007, respectively, and 6.4% and

6.2% in the fourth quarter and fiscal 2006, respectively.

Forward-Looking Statement

Certain statements contained in this news release, including, without limitation, statements containing the words "believes," "anticipates," "intends," "expects," "assumes," "trends" and similar expressions, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based upon the Company's current plans, expectations and projections about future events. However, such statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others: the Company's ability to successfully execute its growth strategy; the impact of significant indebtedness on the Company's liquidity and its ability to meet the requirements of its creditors; general economic and business conditions; demographic changes; changes in, or failure to comply with, existing governmental regulations; legislative proposals for healthcare reform; changes in Medicare and Medicaid reimbursement levels; effects of competition in the markets in which the Company operates; liability and other claims asserted against the Company; ability to attract and retain qualified personnel; availability and terms of capital; loss of significant contracts or reduction in revenues associated with major payer sources; ability of customers to pay for services; business disruption due to implementation of new business systems, or due to natural disasters or terrorist acts; a material shift in utilization within capitated agreements; and changes in estimates and judgments associated with critical accounting policies and estimates. For a detailed discussion of certain of these and other factors that could cause actual results to differ from those contained in this news release, please refer to the Company's various filings with the Securities and Exchange Commission (SEC), including the "Risk Factors" section contained in the Company's annual report on Form 10-K for the year ended December 31, 2006.

Financial and Investor Contact: John R. Potapchuk

631-501-7035

john.potapchuk@gentiva.com

Media Contact: David Fluhrer

631-501-7102,

516-589-0778

david.fluhrer@gentiva.com

revenue growth, and the positive results reported by CareCentrix."
Malone noted these performance highlights for the 2007 fourth quarter:

-- In the Home Health segment, Medicare revenues were up 12% versus the

prior year period, driven by solid performances in both the expanding

specialty programs and in traditional home health services. Overall

segment revenues increased 5%, with the Medicare revenue gain offset

somewhat by a decline in non-Medicare business as Gentiva pursued its

ongoing strategy of exiting or renegotiating relationships that do not

meet certain profitability standards. Operating contribution for the

segment rose 18%. Operating contribution margin was 14.5% versus 12.9%

reported in the fourth quarter of 2006.

-- CareCentrix revenues and operating contribution each rose about 12%

versus the prior year period. Operating contribution margin was 9.4%,

nearly even with that of the fourth quarter of 2006. CareCentrix

continued to benefit from its servicing of increased managed care

membership enrollments among its customers, as well as implementation

of an exclusive contract in Georgia.

-- Gentiva made voluntary loan repayments of $6 million in the fourth

quarter that reduced long-term debt to $310 million at December 30,

2007. Together with the strong operating earnings, this has resulted

in a lower leverage ratio and has triggered a 25 basis point decrease

in the Company's term loan interest rate, effective today.

Malone added that fourth quarter revenues in the Other Related Services segment were about even with the prior year period, while operating contribution declined as Gentiva continued to focus on the segment's future growth prospects.

Gentiva reported the following results for the fiscal years ended December 30, 2007 and December 31, 2006, including the results of The Healthfield Group, Inc. since its acquisition on February 28, 2006:
-- Net revenues increased 11% to $1.23 billion in fiscal 2007 versus the

prior year period.

-- Net income rose 58% to $32.8 million, or $1.15 per diluted share, in

fiscal 2007 versus $20.8 million, or $0.76 per diluted share, for the

prior year period.

-- EBITDA for 2007 increased 44% to $99.7 million versus $69.3 million in

2006. EBITDA for each period included net charges for special items

and restructuring and integration costs of $2.4 million and $5.8

million, respectively.

-- EBITDA and net income per diluted share for 2007, excluding special

items and restructuring and integration costs, were $102.1 million and

$1.20 versus $75.1 million and $0.89 for 2006.

-- Operating cash flow increased 22% to $62.7 million for fiscal 2007 as

compared to $51.4 million for the prior year.

2008 Outlook

Gentiva also announced that it has raised its 2008 financial outlook, which was previewed in the Company's third quarter earnings news release last November. The new outlook reflects the following key metrics:
-- Net revenues in a range between $1.28 billion and $1.32 billion (as

compared to the preview of $1.25 billion to $1.29 billion).

-- EBITDA in a range between $112 million and $117 million.

-- Diluted earnings per share in a range between $1.32 and $1.40 (as

compared to the preview of $1.25 to $1.35).

The 2008 outlook incorporates the following assumptions:

-- No changes during calendar 2008 to either Medicare home health

Prospective Payment System refinements or the Medicare home health

market basket increase of 3%, both of which became effective on January

1, 2008.

-- Inclusion of partial-year results of Home Health Care Affiliates, Inc.,

a recently-announced acquisition in Mississippi, which is expected to

close later in the first quarter.

-- Exclusion of special items, restructuring or non-recurring charges and

other future acquisitions.

"We believe 2008 will be a year of growth and the extension of our industry leadership," Malone said. "We saw examples last week with the announcement of our planned home health acquisition in Mississippi and CareCentrix' signing of a contract with CIGNA HealthCare, which extends their relationship through January 2011.

Non-GAAP Financial Measures

The information provided in this press release includes certain non-GAAP financial measures as defined under Securities and Exchange Commission (SEC) rules. In accordance with SEC rules, the Company has provided, in the supplemental information and the footnotes to the tables, a reconciliation of those measures to the most directly comparable GAAP measures.

Conference Call and Web Cast Details

The Company will comment further on its fourth quarter and fiscal 2007 results during its conference call and live web cast to be held Thursday, February 14, 2008, at 10:00 a.m. Eastern Time. To participate in the call from the United States, Canada or an international location, dial (973) 935-2408 and reference call #31906724. The web cast is an audio-only, one-way event. Web cast listeners who wish to ask questions must participate in the conference call. Log ontohttp://investors.gentiva.com/events.cfm to hear the web cast. This press release is accessible at http://investors.gentiva.com/releases.cfm and a transcript of the conference call is expected to be available on the site within 36 hours after the call.

About Gentiva Health Services, Inc.

Gentiva Health Services, Inc. is the nation's leading provider of comprehensive home health and related services. The Company serves patients across the United States, through its direct service delivery units or through CareCentrix(R), which manages home health services for major managed care organizations. Gentiva is a single source for skilled nursing; physical, occupational, speech and neurorehabilitation services; hospice services; social work; nutrition; disease management education; help with daily living activities; respiratory therapy and home medical equipment; infusion therapy services; and other therapies and services. Gentiva's revenues are generated from federal and state government programs, commercial insurance and individual consumers. For more information, visit Gentiva's web site, http://www.gentiva.com, and its investor relations section at http://investors.gentiva.com. GTIV-E

(tables and notes follow)

(in 000's, except per share data)

4th Quarter Fiscal Year

2007 2006 2007 2006

Statements of Income

Net revenues $313,396 $293,118 $1,229,297 $1,106,588

Cost of services and goods

sold 180,154 169,510 705,592 644,274

Gross profit 133,242 123,608 523,705 462,314

Selling, general and

administrative expenses 113,247 108,471 444,042 408,271

Operating income 19,995 15,137 79,663 54,043

Interest expense (6,636) (7,303) (27,285) (24,685)

Interest income 768 765 3,204 3,284

Income before income taxes 14,127 8,599 55,582 32,642

Income tax expense 5,281 3,087 22,754 11,866

Net income $8,846 $5,512 $32,828 $20,776

Earnings per Share

Net income:

Basic $0.32 $0.20 $1.18 $0.78

Diluted $0.31 $0.20 $1.15 $0.76

Average shares outstanding:

Basic 28,006 27,301 27,798 26,480

Diluted 28,781 28,167 28,599 27,317

Condensed Balance Sheets

ASSETS

Dec 30, 2007 Dec 31, 2006

Cash, cash equivalents and

restricted cash (A) $36,181 $32,910

Short-term investments (B) 31,250 24,325

Accounts receivable, net (C) 207,801 181,549

Deferred tax assets 18,859 30,443

Prepaid expenses and other

current assets 14,415 11,933

Total current assets 308,506 281,160

Fixed assets, net 59,562 49,684

Intangible assets, net 211,602 213,280

Goodwill 276,100 274,959

Other assets 26,463 24,799

Total assets $882,233 $843,882

LIABILITIES AND SHAREHOLDERS' EQUITY

Current portion of long-term

debt $2,304 $-

Accounts payable 20,093 19,580

Payroll and related taxes 17,163 16,085

Deferred revenue 29,015 20,122

Medicare liabilities 7,985 9,232

Cost of claims incurred but

not reported 24,321 19,462

Obligations under insurance

programs 36,816 35,910

Other accrued expenses 42,282 45,020

Total current

liabilities 179,979 165,411

Long-term debt 307,696 342,000

Deferred tax liabilities,

net 48,572 41,065

Other liabilities 22,557 21,081

Shareholders' equity 323,429 274,325

Total liabilities and

shareholders' equity $882,233 $843,882

Common shares outstanding 28,046 27,436

(A) Cash, cash equivalents and restricted cash included restricted cash of

$22.0 million at December 30, 2007 and December 31, 2006.

(B) Short-term investments at December 30, 2007 and December 31, 2006

consisted of AAA-rated auction rate securities.

(C) Accounts receivable, net, included an allowance for doubtful accounts

of $9.4 million and $9.8 million at December 30, 2007 and December 31,

2006, respectively.

(in 000's) Fiscal Year

Condensed Statements of Cash Flows 2007 2006

OPERATING ACTIVITIES:

Net income $32,828 $20,776

Adjustments to reconcile net income to net

cash provided by operating activities:

Depreciation and amortization 20,014 15,241

Amortization of debt issuance costs 1,063 1,028

Provision for doubtful accounts 9,939 9,425

Loss on disposal of assets - 844

Reversal of tax audit reserves (450) (800)

Equity-based compensation expense 6,812 4,281

Windfall tax benefits associated with equity-

based compensation (856) (1,804)

Deferred income taxes 20,923 10,841

Changes in assets and liabilities:

Accounts receivable (36,423) (2,424)

Prepaid expenses and other current assets (3,531) (2,344)

Current liabilities 12,606 (4,695)

Other, net (254) 1,078

Net cash provided by operating activities 62,671 51,447

INVESTING ACTIVITIES:

Purchase of fixed assets (24,064) (24,407)

Acquisition of businesses (3,820) (210,314)

Purchases of short-term

investments available-for-sale (96,850) (176,495)

Maturities of short-term

investments available-for-sale 89,925 201,920

Net cash used in investing activities (34,809) (209,296)

FINANCING ACTIVITIES:

Proceeds from issuance of common stock 7,882 12,400

Windfall tax benefits associated with

equity-based compensation 856 1,804

Proceeds from issuance of debt - 370,000

Healthfield debt repayments - (195,305)

Other debt repayments (32,000) (28,000)

Changes in book overdrafts - (1,395)

Debt issuance costs - (6,930)

Repayment of capital lease obligations (1,329) (432)

Net cash (used in) provided

by financing activities (24,591) 152,142

Net change in cash, cash

equivalents and restricted cash 3,271 (5,707)

Cash, cash equivalents and

restricted cash at beginning of year 32,910 38,617

Cash, cash equivalents and

restricted cash at end of year $36,181 $32,910

SUPPLEMENTAL DISCLOSURES OF

CASH FLOW INFORMATION:

Interest paid $27,469 $17,268

Income taxes paid, net of refunds $2,329 $2,839

(in 000's, except per share data)

Supplemental Information 4th Quarter Fiscal Year

2007 2006 2007 2006

Segment Information

Net revenues (1) (6)

Home Health (2) $207,494 $197,102 $821,829 $746,893

CareCentrix 76,275 68,128 290,786 267,539

Other Related Services 30,575 30,589 121,797 104,660

Intersegment revenues (948) (2,701) (5,115) (12,504)

Total net revenues $313,396 $293,118 $1,229,297 $1,106,588

Operating contribution (1) (5) (6)

Home Health (2) $30,069 $25,481 $122,053 $94,477

CareCentrix 7,180 6,394 29,070 24,740

Other Related Services 3,593 4,773 13,821 18,612

Total operating contribution 40,842 36,648 164,944 137,829

Corporate expenses (3) (15,539) (17,661) (65,268) (68,545)

Depreciation and amortization (5,308) (3,850) (20,013) (15,241)

Interest expense, net (5,868) (6,538) (24,081) (21,401)

Income before income taxes $14,127 $8,599 $55,582 $32,642

4th Quarter Fiscal Year

2007 2006 2007 2006

Net Revenues by Major Payer

Source:

Medicare (2)

Home Health $140,111 $125,321 $549,262 $455,270

Other 15,527 15,788 60,285 53,779

Total Medicare 155,638 141,109 609,547 509,049

Medicaid and local government 36,536 41,830 153,078 174,193

Commercial insurance and'/>"/>

SOURCE Gentiva Health Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Gentiva(R) Health Services and CIGNA HealthCare Extend National Homecare Contract Through January 31, 2011
2. Gentiva(R) Health Services Agrees to Acquire Major Home Health Provider in CON State of Mississippi
3. Gentiva(R) Health Services Promotes Boelsen to Senior Vice President, CareCentrix(R)
4. Gentiva(R) Health Services to Present January 8 at JPMorgan Healthcare Conference in San Francisco
5. Gentiva(R) Health Services to Present November 7 at CIBC Healthcare Conference in New York
6. Gentiva(R) Health Services Schedules Third Quarter Earnings Call and Web Cast for Thursday, November 1, 2007
7. Gentiva(R) Health Services Files Universal Shelf Registration Statement
8. XTend Medical (XMDC) Begins Remote Diabetic Telehealth Program
9. Underserved Women and Children in Oakland County Get Big Boost for Free Health Care from Chrysler 300C Lease Giveaway
10. AIDS Action Asks Mass. Public Health Council to Forge a State AIDS Plan to Help Stop HIV/AIDS Here
11. Is a Common Cold a Serious Health Condition?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... ... While a significant number of women and men with eating disorders report a ... that best predicts the development of an eating disorder. , At the ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... excited to share this important news! AHCC and the Home Health and Hospice ... Clinic, CMS' designee for official ICD coding guidance and clarifications, to address concerns ...
(Date:2/8/2016)... ... February 08, 2016 , ... The schedule is ... this country. The AutismOne 2016 Conference, which is being held May 25-29 at the ... hear elsewhere about helpful interventions and causes of chronic illness in children. , Very ...
(Date:2/7/2016)... Dallas, Texas (PRWEB) , ... February 07, 2016 ... ... its new MyDecision™ program. MyDecision™ empowers employers and organizations with the tools and ... , MyDecision™ combines three elements to cut the cost of providing employee healthcare ...
(Date:2/6/2016)... ... February 06, 2016 , ... With the FCPX LUT: Summer ... grades to their footage. A LUT is a Lookup Table that contains a mathematical ... color indicated by the table. By manipulating each pixel, LUT's can change each color ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... 8, 2016   HighPoint Solutions today ... (NRG),s pharmacovigilance technology services division.  NRG is a ... an Oracle Argus Specialized partner, providing drug safety ... companies. --> --> ... sciences capabilities and provides a global scale and ...
(Date:2/8/2016)... part of a major growth and expansion initiative, Dune Medical ... Chmura as President of Dune Inc., its U.S. division. ... experience in the medical device space will play a large ... --> --> In her new ... and operational functions in the U.S. She is tasked with ...
(Date:2/8/2016)... Feb. 8, 2016 Velano Vascular, a medical ... hospitalized patients and their practitioners, announced today that the ... Velano will use the proceeds from this financing, an ... in January 2015, to support the development and commercialization ... pediatric populations. Philadelphia , ...
Breaking Medicine Technology: